BIO-ME
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €220,000. Estimated: probably between €170,000 and €260,000.
Balance sheet
balance sheet total €32,569 on 30-09-2023in euro
in euro
Position in the sector
63.5%
Higher than 80% of 5,583 companies in 2023.
1.92
Higher than 71% of 5,116 companies in 2023.
-50.0%
Higher than 8% of 5,154 companies in 2023.
Net result: bottom quarter · Equity: middle half · Balance sheet total: middle half · Working capital: middle half
Staff
€35,963
Staff costs divided by the average number of full-time equivalents.
level
In 2023, 1 employee joined and 1 left.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Balance sheet: assets | ||||
20/58 |
32,569 | 60,683 | 34,414 | |
21/28 |
9,821 | 7,871 | 9,550 | |
22/27 |
9,146 | 7,196 | 9,375 | |
23 |
3,125 | 6,250 | 9,375 | |
24 |
6,021 | 946 | - | |
28 |
675 | 675 | 175 | |
29/58 |
22,748 | 52,812 | 24,864 | |
3 |
4,143 | 13,223 | - | |
30/36 |
4,143 | 13,223 | - | |
40/41 |
175 | 3,313 | 3,002 | |
40 |
66 | 3,313 | 1,440 | |
41 |
109 | - | 1,562 | |
54/58 |
18,030 | 34,932 | 21,862 | |
490/1 |
399 | 1,344 | - | |
| Balance sheet: equity and liabilities | ||||
10/49 |
32,569 | 60,683 | 34,414 | |
10/15 |
20,695 | 36,988 | 13,096 | |
10/11 |
2,500 | 2,500 | 2,500 | |
14 |
18,195 | 34,488 | 10,596 | |
17/49 |
11,874 | 23,695 | 21,317 | |
17 |
- | 1,086 | 5,347 | |
170/4 |
- | 1,086 | 5,347 | |
42/48 |
11,874 | 22,609 | 15,971 | |
42 |
1,086 | 4,261 | 4,134 | |
44 |
6,030 | 6,118 | 1,658 | |
440/4 |
6,030 | 6,118 | 1,658 | |
45 |
3,470 | 11,229 | 5,590 | |
450/3 |
3,470 | 7,395 | 5,590 | |
454/9 |
- | 3,834 | - | |
47/48 |
1,287 | 1,001 | 4,589 | |
| Income statement | ||||
9900 |
91,850 | 102,208 | 51,546 | |
62 |
100,696 | 87,608 | 46,857 | |
630 |
6,240 | 3,526 | 3,125 | |
640/8 |
668 | 291 | 864 | |
66A |
- | 1,391 | 500 | |
9901 |
-15,754 | 9,392 | 199 | |
75/76B |
204 | 17,095 | 11,000 | |
75 |
204 | 17,095 | 11,000 | |
65/66B |
742 | 919 | 603 | |
65 |
742 | 919 | 603 | |
9903 |
-16,292 | 25,568 | 10,596 | |
67/77 |
- | 1,677 | - | |
9904 |
-16,292 | 23,891 | 10,596 | |
9905 |
-16,292 | 23,891 | 10,596 | |
| Appropriation of the result | ||||
9906 |
18,195 | 34,488 | 10,596 | |
14P |
34,488 | 10,596 | - | |
| Social balance sheet | ||||
9087 |
2.8 | 2.6 | 3.7 | |
Hours worked1013 |
3,568 | 3,300 | 2,121 | |
| Document | ||||
The notes to these accounts have 7 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).
Source: Annual accounts 2023 (PDF), filed on 20-03-2024.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| -9,515 | 12,918 | 3,324 | ||
| -10,053 | 27,417 | 13,721 | ||
| 8,190 | 1,847 | 12,675 | ||
| -16,902 | 13,069 | - | ||
| 10,874 | 30,202 | 8,893 | ||
| 63.5% | 61.0% | 38.1% | ||
| 1.92 | 2.34 | 1.56 | ||
| 1.57 | 1.75 | 1.56 | ||
| 0.57 | 0.64 | 1.63 | ||
| -78.7% | 64.6% | 80.9% | ||
| -50.0% | 39.4% | 30.8% | ||
| -12.83 | 14.06 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Social balance sheet
| Item | 30-09-2023 | 30-09-2022 |
|---|---|---|
| Employees at the balance-sheet date | 3 | 3 |
| part-time | 3 | 3 |
| in full-time equivalents | 2.1 | 1.9 |
| 2 | 1.9 | |
| On a permanent contract | 2 | 3 |
| Joined | 1 | 2 |
| Left | 1 | 3 |
Source: social balance sheet in the 2022 to 2023 annual accounts
Investments
fixed assets acquired| Item | 30-09-2023 | 30-09-2022 |
|---|---|---|
| Tangible fixed assets | €8,190 | €1,347 |
| Financial fixed assets | - | €500 |
| €6,240 | €3,526 |
Source: notes to the 2022 to 2023 annual accounts (statement of fixed assets)
Insights on BIO-ME
The operating result for 2023 is a loss of €15,754, after a profit of €9,392 in 2022. It is the lowest result since 2021.
Debt's share of the balance-sheet total falls from 39.0% to 36.5%. Equity and debt are lower.